Imperial Brands Plans to Cut Nearly 18% of Workforce as German Plant Closure and Polish Outsourcing Drive Restructuring

company
Nov.18
Imperial Brands Plans to Cut Nearly 18% of Workforce as German Plant Closure and Polish Outsourcing Drive Restructuring
Imperial Brands disclosed on November 17, 2026, that its global manufacturing and organisational restructuring is expected to reduce between 4,200 and 4,600 roles by the end of 2030, equivalent to approximately 16%–18% of its workforce at the end of 2025. The first phase covers 2,100 roles with departures confirmed or subject to consultation, while a further 2,100–2,500 positions are expected to be eliminated by 2030. The company is proceeding with the closure of its Langenhagen factory in Germany, has sold its manufacturing facility in Taiwan, and has transferred selected finance, procurement and supply-chain operations in Poland to Capgemini. The restructuring programme is expected to cost approximately £740 million, with Imperial targeting at least £320 million in annual cost savings by 2030.

Key Points

  • Imperial Brands expects cumulative reductions of 4,200–4,600 roles by 2030, equivalent to approximately 16%–18% of its 25,800 employees at the end of 2025.
  • The first 2,100 departures have been confirmed or remain under consultation, with a further 2,100–2,500 roles expected to be eliminated by 2030.
  • The company is closing its Langenhagen plant in Germany, has sold its Taiwan factory for £54 million, and transferred selected Polish support operations to Capgemini.
  • Imperial recognised £327 million in fiscal 2026 restructuring costs, including £49 million in severance costs.
  • The programme is expected to cost approximately £740 million in total. Imperial delivered £90 million in annualised savings in fiscal 2026 and targets at least £320 million a year by 2030.

2Firsts

November 18, 2026

Imperial Brands plans to cut up to 4,600 jobs worldwide by the end of 2030, equivalent to nearly 18% of its workforce at the end of 2025, as the British tobacco group closes conventional tobacco manufacturing facilities, disposes of production assets, transfers support operations and expands the use of digital technology.

The company said in its November 17 fiscal 2026 results and investor presentation that the first phase covers 2,100 roles with departures confirmed or still under consultation. A further 2,100–2,500 positions are expected to be eliminated by the end of 2030, bringing the cumulative reduction to between 4,200 and 4,600 roles.

Imperial is targeting annual cost savings of at least £320 million (approximately $420 million) by 2030 through a restructuring programme expected to cost around £740 million.

Chief Executive Lukas Paravicini told reporters that the changes were intended to improve efficiency while making the group more data-driven, faster at innovation and more responsive to changing consumer demand, according to Reuters.

Up to 4,600 Roles Targeted as Restructuring Extends Through 2030

The job reductions form part of Imperial Brands' 2030 Strategy, announced in March 2025, covering manufacturing, procurement, logistics, corporate support functions and digital technology.

According to the company's fiscal 2026 investor presentation, the first phase covers approximately 2,100 roles, with departures either confirmed or under consultation. That figure does not mean all affected employees have already left the business.

Imperial expects to eliminate a further 2,100–2,500 roles by the end of 2030.

Based on its workforce of approximately 25,800 employees at the end of 2025, the combined reductions represent around 16%–18% of the group.

Sky News reported that the initial restructuring includes manufacturing facilities in Germany and Taiwan, involving approximately 700 employees. The Langenhagen plant in Germany alone employed around 640 workers when the closure plan was announced.

Imperial has not published a complete country-by-country or business-unit breakdown of the further planned reductions. Sky News reported that UK employees are expected to account for a relatively small proportion of the cuts.

The company said the changes would proceed under applicable employee consultation procedures.

German Plant Closure and Taiwan Factory Disposal Reshape Manufacturing Network

Manufacturing consolidation is a significant component of Imperial's restructuring programme.

In October 2025, the company announced plans to cease production at the Langenhagen factory in Germany, operated by its subsidiary Reemtsma. The facility manufactured conventional tobacco products and employed approximately 640 people at the time.

Imperial cited the long-term decline in demand and production volumes for combustible tobacco products, resulting in lower utilisation of manufacturing capacity.

During fiscal 2026, the group completed employee consultations relating to the Langenhagen closure and continued preparations for ceasing operations and managing the site.

The latest financial statements estimate total closure costs of approximately £220 million, including £182 million recognised in fiscal 2026.

The fiscal 2026 amount comprises £77 million in provisions for employee-related costs, a £69 million retirement benefit liability, £18 million in site decommissioning provisions and £18 million in project, legal, consultancy and machinery relocation costs.

Separately, Imperial recognised a £101 million impairment charge against the factory's assets in fiscal 2025. That charge is in addition to the estimated £220 million closure cost.

In Asia, Imperial completed the disposal of its Taiwan manufacturing facility during fiscal 2026. The transaction included land, buildings and machinery, generating £54 million in proceeds.

The company recognised a £27 million gain on the disposal and £11 million in costs associated with subsequently exiting the site.

The Taiwan transaction involved the sale of manufacturing assets. Imperial did not announce a complete withdrawal from the Taiwanese tobacco market.

Imperial's conventional tobacco volumes declined 3.4% in fiscal 2026 to 180.6 billion stick equivalents. The group attributed part of the reduction to lower private-label production in Germany and weaker demand in European tobacco markets.

Capgemini Takes Over Polish Support Operations as Shared Services and AI Expand

Imperial is also reorganising finance, procurement, supply-chain management and other corporate support functions.

In February 2026, the company announced a partnership with French technology and consulting group Capgemini. In April, Imperial transferred its finance, procurement and supply-chain hubs in Poland to Capgemini, recognising a £28 million gain on the transaction during the fiscal year.

The partnership includes an Intelligent Business Hub through which Capgemini will manage selected shared services for Imperial's business units and geographic markets.

The Guardian reported that approximately 400 positions in Poland were associated with the transfer of support functions. Imperial has not separately disclosed how many of those employees were made redundant.

Alongside the outsourcing arrangement, the tobacco group is upgrading its enterprise resource planning (ERP) systems, with new platforms deployed in Australasia and at the Radom manufacturing site in Poland.

Imperial has also introduced an AI-powered sales assistant for teams in Europe and the United States. Its November 17 investor presentation said the tool could reduce sales preparation time by up to one-third.

The Capgemini partnership also covers enterprise data management, process automation and artificial intelligence.

Imperial has not disclosed how many jobs within its wider restructuring programme are being directly replaced by AI systems.

£740 Million Programme Targets at Least £320 Million in Annual Savings by 2030

Imperial estimates the total cost of its 2030 Strategy restructuring programme at approximately £740 million, including around £600 million in cash costs and £140 million in non-cash charges.

Approximately £500 million of the cash expenditure is expected to fall in fiscal 2027 and fiscal 2028.

In fiscal 2026, the company recognised £327 million in costs associated with the programme, while cash expenditure amounted to £118 million.

The recognised costs comprised £182 million related to the Langenhagen factory closure and £145 million associated with wider organisational changes.

The £145 million of organisational costs included £49 million in severance expenses, £26 million for internal programme staff, £26 million for external partner support and £44 million in other costs.

Imperial said it delivered approximately £90 million in annualised savings in fiscal 2026, including around £25 million from manufacturing improvement initiatives. Additional savings came from procurement, production planning, logistics and optimisation of the manufacturing footprint.

Measures implemented since the 2030 Strategy began are expected to support approximately £180 million in future annualised savings, including the £90 million already delivered.

The group's target is to increase annual savings to at least £320 million by 2030.

The programme is taking place as Imperial's conventional tobacco business faces continued volume pressure. Fiscal 2026 tobacco volumes declined 3.4%, but pricing increased 5.1%, allowing tobacco net revenue to rise 1.7% at constant currency.

Meanwhile, net revenue from next-generation products (NGP), including blu vaping products, Pulze heated tobacco devices and zone nicotine pouches, increased 11.4% at constant currency. The NGP business nevertheless recorded an adjusted operating loss of £63 million.

Imperial has not disclosed the full allocation of planned job reductions among combustible tobacco operations, next-generation nicotine businesses and corporate shared services.

Follow 2Firsts for developments in global tobacco companies' restructuring, manufacturing operations, next-generation nicotine products and corporate strategies.

Cover Image:Imperial Brands

U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
Combined tobacco and vaping sales in UK convenience stores fell 10.6% year over year in the first half of 2026, making the category a major drag on channel performance, according to retail research organization IGD. Total convenience sales declined 1.2%, while sales excluding tobacco and vaping increased 0.7%. IGD's 2026 category-share figures show tobacco and vaping accounting for 15.4% of convenience sales, compared with 15.1% for alcohol. The organization forecasts alcohol could overtake tobacco and vaping as the largest category by sales value as early as 2027 if current trends continue. IGD expects the convenience market to increase from £48.6 billion in 2026 to £54.9 billion in 2031, a 2.5% compound annual growth rate, or 3.4% excluding tobacco and vaping.
DATA
Nov.11
Hawaii's Largest Independent Vape Retailer and Wholesaler Volcano to Close All 13 Stores Ahead of 2027 Sales Rules
Hawaii's Largest Independent Vape Retailer and Wholesaler Volcano to Close All 13 Stores Ahead of 2027 Sales Rules
Hawaii-based vaping company Volcano eCigs plans to close all 13 physical retail stores on December 31, 2026, affecting approximately 56 employees. Volcano operates retail, wholesale, proprietary product and online sales businesses and has previously described itself in legislative testimony as Hawaii's largest independent vape retailer and wholesaler. Its operating company, Jocor Enterprises LLC, filed a formal closure notice on November 4, citing changes in the state's regulatory environment. From January 1, 2027, Hawaii will restrict the sale, acquisition and possession of vaping devices and e-liquids not listed in a state product directory, alongside separate restrictions on certain disposable devices. The closure concerns Volcano's physical retail network; the company has not announced the termination of wholesale or online operations.
Market
Nov.09
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26